As per Future Market Insights’ latest industry analysis, the global preclinical medical device testing services market accumulated US$ 6 Billion in 2021, and is expected to garner US$ 6.72 Billion by 2022. The market is expected to gain US$ 20.87 Billion by 2032 while expanding at a staggering double-digit CAGR of 12% from 2022 to 2032. Growth of the market is attributed to the strict regulations imposed by governmental bodies to maintain safety standards.
| Attributes | Details |
| Global Preclinical Medical Device Testing Services Market CAGR (2022-2032) | 12% |
| Global Preclinical Medical Device Testing Services Market (2032) | US$ 20.87 Billion |
| Global Preclinical Medical Device Testing Services Market Attraction | Technologically advanced devices along with regulations are propelling the growth of preclinical medical device testing market. |
Integration of artificial intelligence along with Internet of Things is playing a key role in advancing preclinical medical device testing services. In addition, the growing burden of treating diseases at an early stage is creating opportunities for the development of preclinical medical device testing services. Manufacturers too are researching and analyzing preclinical devices to solve problems related to the same at an early stage. This, in turn, is driving the demand for preclinical medical device testing services.
On the contrary, incompatible sterilization measures along with equipment sensitivity is derailing the progress of the market. In addition, approvals of preclinical medical devices differ from region to region. This, in turn, is hampering the growth of the overall market.
Get a Sample Copy of Report@
https://www.futuremarketinsights.com/reports/sample/rep-gb-14994
Key Takeaways from the Market Study
- Global preclinical medical device testing services market is expected to flourish 3x from 2022-2032
- Microbiology and sterility testing expected to possess a market share for 35%
- U.S projected to lead the market by expanding at a CAGR of 18% during the forecast period.
- India expected to register a CAGR of 13% for preclinical medical device testing services in the assessment period 2022-2032
- Switzerland to be an emerging hub across Europe, expected to reflect a 10% value CAGR until 2032
Competitive Landscape
Key market players in the preclinical medical device testing services are Eurofins Scientific, Nelson Labs, North American Science Associates, Inc, WUXI APPTEC, SGS SA, Labcorp, TÜV SÜD AG, Sterigenics International LLC, Pace Analytical Services LLC, Intertek Group Plc, Charles River Laboratories International, Inc. Some of the recent key developments among the players are:
- In February 2022, Eurofins acquired Genetic Testing Service JSC from Vietnam. Through this expansion, the company is planning to expand its presence in Asia and strengthen its global network of advanced genetic testing.
- In September 2021, Nelson Labs and Sterigenics have collaborated to open a state of art laboratory and expand sterilization facilities to meet growing customer demand in Europe.
For any Queries Linked with the Report, Ask an Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-14994
Key Segments Covered in the Preclinical Medical Device Testing Services Market Report
Preclinical Medical Device Testing Services Market by Service:
- Preclinical Biocompatibility Medical Device Tests
- Preclinical Medical Device Chemistry Test
- Preclinical Medical Device Microbiology & Sterility Testing
- Bioburden Determination
- Pyrogen & Endotoxin Testing
- Sterility Test and Validation
- Antimicrobial Activity Testing
- Others
- Preclinical Medical Device Package Validation
Preclinical Medical Device Testing Market by Region:
- North America Preclinical Medical Device Testing Services Market
- Latin America Preclinical Medical Device Testing Services Market
- Europe Preclinical Medical Device Testing Services Market
- Asia Pacific Preclinical Medical Device Testing Services Market
- Middle East & Africa Preclinical Medical Device Testing Services Market
Request advisory customization available@
https://www.futuremarketinsights.com/customization-available/rep-gb-14994
More Valuable Insights Available
FMI, in its new offering, presents an unbiased analysis of the global preclinical medical device testing services market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights by Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing), & Region Forecast till 2032
Read Related Reports:
https://vocal.media/stories/liquid-biopsy-market-2022-scope-of-current-and-future-industry-2031
https://degentevakana.com/blogs/view/118096
https://degentevakana.com/blogs/view/118100
https://vocal.media/stories/dental-imaging-equipment-market-2022-scope-of-current-and-future-industry-2030
About FMI
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/preclinical-medical-device-testing-services-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs